We feel @benchling combines 3 things we love @MenloVentures: outstanding vertical SaaS, huge impact in life sciences, and fantastic entrepreneurs we love working with. Excited to help support the team with @mmurph. https://t.co/sGcfOFyM8e
— Greg Yap (@grgyap) July 24, 2019
In a field where the laboratory notebook is still considered the state of the art, it’s no wonder a company like @benchling, which provides #software for managing #lifesciences #research, was able to nab $34.5 million. https://t.co/7jDzA8GGSa @jshieber #synbio #biotech #biopharma
— SynBioBeta (@SynBioBeta) July 25, 2019
Ecstatic to be partnering w/ @Benchling : Fantastic founders ( @sajithw @daashu ), terrific mission, great product, and hyper efficient growth! "Benchling software for managing biotech research nabs $34.5 million." https://t.co/gKuKoHgfYF via @techcrunch
— mmurph (@mmurph) July 24, 2019
We're excited to share our Series C funding and what this means for our product, our customers, and our team! With this investment, we'll support deeper engagements with customers and empower more cutting-edge scientists. https://t.co/AsPBzHMolp
— Benchling (@benchling) July 24, 2019